SARM S-23, a non-steroidal selective androgen receptor modulator, has garnered significant attention in the ASIA scientific community. It is renowned for its remarkable binding affinity, making it a focal point in muscle and bone health research. Numerous ASIA studies have explored the potential of S-23 to selectively modulate androgen receptors, offering therapeutic benefits for muscle-wasting disorders and osteoporosis. This compound holds great promise for advancing our understanding and treatment of these conditions.
S-23 is available as capsules, powders, and liquid droppers, making it versatile within research settings. Please note, S-23 is strictly for research purposes and not intended for human consumption.